Could a molecular switch repair central nervous system disorders?

via Mayo Clinic

Article Highlights

A molecular switch has the ability to turn on a substance in animals that repairs neurological damage in disorders such as multiple sclerosis (MS)
The early research in animal models could advance an already approved Food and Drug Administration therapy and also could lead to new strategies for treating diseases of the central nervous system.
"This sets the stage for development of new clinically relevant myelin regeneration strategies."
"It is important to say that we have not and are not advocating that patients take this inhibitor at this time," says Dr. Scarisbrick. "We have not used the drug in animals yet, and it is not ready to put in patients for the purpose of myelin repair. Using cell culture systems, we are showing that this has the potential to improve myelin regeneration.”
Additional research is needed to verify and advance the findings toward clinical practice.

Tick-borne Powassan virus reported in Massachusetts: ‘The virus can invade the central nervous system’
A confirmed case of the tick-borne Powassan virus has been reported in Massachusetts, according to officials who are warning residents to take precautions against the disease.
What Is Red Ear Syndrome (RES)?
Red ear syndrome (RES) is a very rare disorder. It causes redness with moderate to severe burning on the outside of one or both ears. An episode of red ear syndrome can occur without a known cause or ...
Psychology class: Nervous system disorders found to be biggest cause of poor health
Look at the table ‘the 10 most damaging neurological conditions’. What is the meaning of DALY for these conditions?
Purinergic signalling and disorders of the central nervous system
Purinergic signalling has important roles in various pathophysiological conditions of the central nervous system (CNS) including: trauma, ischaemia, neurodegenerative diseases (including Parkinson ...
Diseases of the nervous system articles from across Nature Portfolio
The recent approval of omaveloxolone for the treatment of Friedreich ataxia in the USA and Europe represents an important milestone in the field of rare neurological diseases. However, many ...

[google_news title=”” keyword=”central nervous system disorders” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]

MTEM Molecular Templates, Inc.
Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases in ...
MOLN Molecular Partners AG
Molecular Partners AG ... specific T cell-engaging DARPin for acute myeloid leukemia. It also develops Switch-DARPin platform, a multispecific cKIT x CD16a x CD47 Switch-DARPin program for ...
Research combines DNA origami and photolithography to move one step closer to molecular computers
Molecular computer components could represent a new IT revolution and help us create cheaper, faster, smaller, and more powerful computers. Yet researchers struggle to find ways to assemble them more ...
Enhanced CRISPR method enables stable insertion of large genes into the DNA of higher plants
Scientists at the Leibniz Institute of Plant Biochemistry (IPB) have succeeded for the first time in stably and precisely inserting large gene segments into the DNA of higher plants very efficiently.
Lung Cancer Cells Switch Oncogenic Drivers
Mouse models mimicking the transition from a common form of lung cancer to a more aggressive one may help scientists develop future strategies to prevent this transformation.

[google_news title=”” keyword=”molecular switch” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]

Don't Like it!

I Like it!

The Latest Updates from Bing News & Google News